Latest News Archive

Please select Category, Year, and then Month to display items
Previous Archive
23 September 2019 | Story Xolisa Mnukwa | Photo Barend Nagel
Prof Puleng LenkaBula
“I want to establish a paradigm shift from community engagement to engaged scholarship, which will transfer science between communities and form reciprocal collaborations in order to create new knowledge, research niche areas, influences, and support systems to aid innovative and progressive teaching and learning processes at the UFS.” – Prof LenkaBula

The University of the Free State (UFS) Vice-Rector: Institutional Change, Student Affairs, and Community Engagement, Prof Puleng LenkaBula, recently visited the Fulda University of Applied Sciences in Germany to discuss a possible future collaboration between the two institutions.

This was inspired by their multidisciplinary approach to higher-education courses, which she aims to facilitate at the UFS in order to pioneer critical thinking among students to ultimately bring about effective and innovative societal problem-solving in South Africa.

Fulda University is an exceptional higher-education institution with the ability to develop and transform itself to purposefully improve its infrastructure, the quality of students, and studies offered by the university. Their different degrees are structured to intersect with the requirements of the progressive European economic environment.

According to Prof LenkaBula, Fulda University is an outstanding institution specialising in applied sciences and theoretical studies, which set them apart from other universities in the advanced European higher-education system.

Prof LenkaBula believes that the prospect of developing joint master’s and/or doctoral degrees between the UFS and Fulda University would expose UFS students to high-quality international higher-education systems. This will ensure that our students are provided with essential skills to become globally competitive and relevant in their designated career fields, and to become strong contenders in an environment characterised by globalisation and the 4th Industrial Revolution (4IR).
She referred to the global exchange of knowledge systems between the UFS and Fulda University as an opportunity for the UFS to improve the university’s global rankings through learning and participating in international collaborative approaches in higher education. 

“In order for our university to cease being seen as an ivory tower, it must be involved in producing knowledge that is beneficial to socio-economic and political development – not only for South Africa, but also for the rest of the world,” said Prof LenkaBula.


News Archive

UFS to monitor the use of ARV-drugs on pregnant women and children
2004-12-08

The University of the Free State (UFS) is to establish a Pharmacovigilance Centre that will monitor the effects of Anti-Retroviral (ARV) drugs on HIV positive pregnant women and children starting early in the new year.

The UFS is one of only two institutions chosen by the Minister of Health, Dr Manto Tshabalala-Msimang, to establish such an ARV monitoring centre.

The other centre will be based at Medical University of South Africa (MEDUNSA) and will concentrate mainly on monitoring the effects of the drugs on adults.

“The establishment of the UFS’s Pharmaconvigilance Centre forms part of government’s Comprehensive Plan on HIV and AIDS, often termed the roll-out plan for ARV drugs. The centre’s primary responsibility will be to specifically monitor the use of these drugs in pregnant women, and children under the age of 13,” said Prof Andrew Walubo of the UFS’s Department of Pharmacology.

“Although most of the side effects of ARV drugs have been identified in other countries, it has now become critical to identify the side effects amongst the South African population. This is important because many people will be exposed to the drugs within a short time. Our aim is so identify the most common side effects and make recommendations for the prevention thereof. The centre will help in detecting the risk of using anti-retroviral drugs in pregnancy and children, and prevention of adverse drug reactions,” said Prof Walubo.

According to Prof Walubo 12 drugs will be monitored – these drugs will be selected according to the patient’s profile.

The centre will comprise of two components: A pregnancy registry, which will focus on a new-born child up until two months and a pediatric registry, which will focus on children who are born of mothers who used ARV drugs and children using ARV drugs.

According to Prof Walubo, the Pharmaconvigilance Centre will also be responsible for offering relevant technical advice, training and selected research on ARV drugs in these patients.

The centre will be fully sponsored by the national Department of Health. It will be based in the UFS’s Faculty of Health Sciences, Department of Pharmacology, and will be run in collaboration with experts from different departments in the faculty.

Media release
Issued by: Lacea Loader
Media Representative
Tel: (051) 401-2584
Cell: 083 645 2454
E-mail: loaderl.stg@mail.uovs.ac.za
8 December 2004

We use cookies to make interactions with our websites and services easy and meaningful. To better understand how they are used, read more about the UFS cookie policy. By continuing to use this site you are giving us your consent to do this.

Accept